
Thyrocare Technologies
Thyrocare Technologies Limited is India's first fully automated diagnostic laboratory.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor | €0.0 | round | |
INR45.5b | Acquisition | ||
Total Funding | 000k |




INR | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 14 % | 19 % | (11 %) | 9 % | 20 % | 16 % | 16 % |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 35 % | 40 % | 25 % | 26 % | 30 % | 28 % | 30 % |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 23 % | 30 % | 12 % | 12 % | 13 % | 16 % | 17 % |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Thyrocare Technologies Limited is a pioneering clinical diagnostic laboratory that specializes in providing high-quality diagnostics and preventive healthcare services at affordable rates. Operating in a B2B model, Thyrocare partners with multiple healthcare players and industries to integrate diagnostics into their service portfolios. The company boasts a robust network with 800 phlebotomists covering 4500 pincodes, ensuring extensive reach and accessibility.
Thyrocare operates a Central Processing Laboratory (CPL) in Mumbai, India, for specialized esoteric tests and has Regional Processing Laboratories in major metro cities across India. This infrastructure enables the company to offer a wide range of tests and profiles, particularly focusing on metabolic diseases, at competitive prices. Thyrocare's services are available in over 2000 cities and towns in India and internationally, making it one of the most advanced and widespread diagnostic service providers.
The business model revolves around automation and scale, which allows Thyrocare to maintain low operational costs while delivering high-quality services. Revenue is generated through partnerships with hospitals, laboratories, and healthcare providers who utilize Thyrocare's diagnostic services as part of their offerings.
Keywords: automated diagnostics, preventive healthcare, B2B partnerships, phlebotomists, metabolic tests, esoteric tests, Central Processing Laboratory, affordable rates, extensive reach, healthcare integration.
Tech stack
Investments by Thyrocare Technologies
Edit